Evidence map›Paper›PMID 39628123›Full record

ArticleBJPsych open2024

The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis.

Jessica Nicholls-Mindlin, Hadar Hazan, Bin Zhou, Fangyong Li, Maria Ferrara, Nina Levine, Sarah Riley, Sneha Karmani, Walter S Mathis, Matcheri S Keshavan and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJPsych open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jessica Nicholls-MindlinMedical Sciences Division, University of Oxford, Oxford, UK; and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID https://orcid.org/0009-0006-0589-4877
Hadar HazanProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.
Bin ZhouYale Centre for Analytical Sciences (YCAS), Yale School of Public Health, New Haven, Connecticut, USA.
Fangyong LiYale Centre for Analytical Sciences (YCAS), Yale School of Public Health, New Haven, Connecticut, USA.
Maria FerraraProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA; and Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrrara, Ferrara, Italy.
Nina LevineProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.
Sarah RileyProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.
Sneha KarmaniProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.
Walter S MathisProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.
Matcheri S KeshavanBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Vinod H SrihariProgram for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0003-1556-2332

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
STEP-ED:Reducing Duration of Untreated Psychosis and its Impact in the U.S.R01MH103831 · NIMH · YALE UNIVERSITY · PI SRIHARI, VINOD H. · 2013 to 2017
$3.9M
CLC NIH HHS R01MH103831Gustavus and Louise Pfeiffer Research FoundationNCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH103831
6 · The paper itself

Abstract

We investigated the impact of COVID-19 restrictions on the duration of untreated psychosis (DUP). First-episode psychosis admissions (

Indexed as

COVID 19duration of untreated psychosisfirst-episode psychosispathways to carePsychotic disorders/schizophrenia

Identifiers

PMID39628123
PMCPMC11698182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.